Filter Results:
(3,439)
Show Results For
- All HBS Web
(3,439)
- People (15)
- News (635)
- Research (2,010)
- Events (12)
- Multimedia (25)
- Faculty Publications (1,575)
Show Results For
- All HBS Web
(3,439)
- People (15)
- News (635)
- Research (2,010)
- Events (12)
- Multimedia (25)
- Faculty Publications (1,575)
Page 1 of 3,439
Results →
- February 2024 (Revised April 2024)
- Case
Finberg: Corporate Venture Capital in Türkiye
By: Paul A. Gompers and Namrata Arora
In December 2021, Murat Özyeğin, Chairman of Fiba Holding, along with Ömer Mert and İhsan Elgin, engaged in discussions about the future of United Payment, a fintech company in which Finberg, a subsidiary of Fibabanka, held a 20% stake. Finberg, established in 2018 as... View Details
Keywords: Corporate Venture Capital; Technology; Return On Investment; Venture Capital; Investment; Strategy; Technological Innovation; Competition; Valuation; Acquisition; Business Startups; Information Technology Industry; Banking Industry; Middle East; North Africa; Turkey; Ukraine; Romania; Poland
Gompers, Paul A., and Namrata Arora. "Finberg: Corporate Venture Capital in Türkiye." Harvard Business School Case 824-175, February 2024. (Revised April 2024.)
- Teaching Interest
Economics of Entrepreneurship and Venture Capital
Designed for Harvard College sophomores.
Course Description: Why do so many individuals choose to pursue entrepreneurship despite substantial risks? How do these entrepreneurs raise money to finance their ventures? And what is the impact of... View Details
- 22 May 2014
- News
To Crack the Glass Ceiling, Start with Venture Capital
- March 2017 (Revised January 2019)
- Case
Aspect Ventures
By: Paul Gompers, Danielle Li and Silpa Kovvali
Gompers, Paul, Danielle Li, and Silpa Kovvali. "Aspect Ventures." Harvard Business School Case 217-046, March 2017. (Revised January 2019.)
- January 2014
- Teaching Plan
MedImmune Ventures
By: Richard Hamermesh and Andrew Otazo
"MedImmune Ventures" highlights the problems faced by corporate venture capital firms, the challenges of investing in early-stage healthcare, and the difficulty of operating in distant markets. View Details
Keywords: MedImmune Ventures; NeuProtect; Corporate Venture Capital; Ron Laufer; Australia; Starfish Ventures; AstraZeneca; MEVE; Healthcare; Startup; Venture Capital; Business Startups; Health Industry; Australia; United States
Hamermesh, Richard, and Andrew Otazo. "MedImmune Ventures." Harvard Business School Teaching Plan 814-039, January 2014.
- 29 Apr 2008
- Research Event
Venture Capital
Date: January 9-10, 2008 Faculty Chairs: Josh Lerner, William Sahlman Faculty Summary Report: Colloquium: Venture Capital What were the overall goals of the colloquium? The VC Conference is one in a series... View Details
Venture Capital Journey
Venture Capital Journey (VCJ) is an MBA elective field course for students who plan to embark on a career in venture capital. The focus of the course is to provide students with frameworks, tools, a network, and hands on experience in preparation... View Details
- October 2019 (Revised January 2020)
- Case
NewView Capital and Venture Capital Secondaries
By: Shai Bernstein, Ramana Nanda and Allison Ciechanover
While still a general partner at Silicon Valley–based New Enterprise Associates (NEA), Ravi Viswanathan considered the challenges presented by evolving market dynamics in the venture capital space. Startups were staying private longer, which led to limited partners... View Details
Bernstein, Shai, Ramana Nanda, and Allison Ciechanover. "NewView Capital and Venture Capital Secondaries." Harvard Business School Case 820-038, October 2019. (Revised January 2020.)
The Venture Capital Cycle
In The Venture Capital Cycle, Paul Gompers and Josh Lerner correct widespread misperceptions about the nature and role of the venture capitalist and provide an accessible and comprehensive overview of the venture capital industry. Bringing together fifteen... View Details
- 2023
- Working Paper
Fencing Off Silicon Valley: Cross-Border Venture Capital and Technology Spillovers
By: Ufuk Akcigit, Sina T. Ates, Josh Lerner, Richard Townsend and Yulia Zhestkova
The treatment of foreign investors is a contentious topic in U.S. entrepreneurship policy. We
model a setting where foreign corporate investments in Silicon Valley may allow U.S. entrepreneurs
to pursue technologies that they could not otherwise, but may also lead to... View Details
Keywords: Innovation; Corporate Venture Capital; Knowledge Spillovers; Innovation and Invention; Foreign Direct Investment; Venture Capital; Entrepreneurship; Policy; United States
Akcigit, Ufuk, Sina T. Ates, Josh Lerner, Richard Townsend, and Yulia Zhestkova. "Fencing Off Silicon Valley: Cross-Border Venture Capital and Technology Spillovers." Harvard Business School Working Paper, No. 21-043, September 2020. (Revised September 2023. Conditionally Accepted, Journal of Monetary Economics.)
- February 2013
- Article
Institutions and Venture Capital
By: Josh Lerner and Joacim Tag
We survey the literature on venture capital and institutions and present a case study comparing the development of the venture capital market in the United States and Sweden. Our literature survey underscores that the legal environment, financial market development,... View Details
Keywords: Venture Capital; Organizations; Taxation; Entrepreneurship; Financial Markets; United States; Sweden
Lerner, Josh, and Joacim Tag. "Institutions and Venture Capital." Industrial and Corporate Change 22, no. 1 (February 2013): 153–182.
- 2004
- Chapter
Venture Capital
By: Paul Gompers and Josh Lerner
Keywords: Venture Capital
Gompers, Paul, and Josh Lerner. "Venture Capital." Chap. D5 of Handbook of Modern Finance, edited by James Seward and Dennis Logue. New York: Warren, Gorham & Lamont, 2004.
- April 2022
- Case
Pear Venture Capital
By: Jo Tango and Alys Ferragamo
Keith Bender, Principal at Pear Venture Capital, is working over the weekend to prepare for a Monday morning investment meeting. He has three startup pitch decks in front of him, and he must choose one to recommend at the meeting. He finds that each company has its... View Details
Keywords: Seed Investing; Seed Financing; Startup; Decision Choices and Conditions; Presentations; Business Startups; Investment; Venture Capital; United States
Tango, Jo, and Alys Ferragamo. "Pear Venture Capital." Harvard Business School Case 822-097, April 2022.
- August 2013 (Revised October 2013)
- Case
MedImmune Ventures
By: Richard G. Hamermesh and David Lane
Ron Laufer is the new Senior Managing Director of MedImmune Ventures, the corporate venture capital arm of AstraZeneca, a leading pharmaceuticals firm. Laufer has to decide whether to pursue a high-potential, but very risky, early-stage investment. The decision Laufer... View Details
Keywords: MedImmune; MedImmune Ventures; AstraZeneca; NeuProtect; Corporate Venturing; Biotechnology; Venture Investing; Venture Capital; Health Care and Treatment; Pharmaceutical Industry; Financial Services Industry; Biotechnology Industry; United States; Australia; Europe; London
Hamermesh, Richard G., and David Lane. "MedImmune Ventures." Harvard Business School Case 814-023, August 2013. (Revised October 2013.)
- March 2001 (Revised February 2005)
- Case
Venture Capital Vignettes
By: G. Felda Hardymon
Presents three fictionalized but realistic situations in which a venture capitalist may find himself. One situation requires crisis intervention to quell a dispute between a vice president of sales and a CEO; another poses the problem of working out the composition of... View Details
Keywords: Venture Capital; Crisis Management; Governing and Advisory Boards; Management Teams; Executive Compensation; Situation or Environment; Employee Relationship Management; Problems and Challenges; Financial Services Industry
Hardymon, G. Felda. "Venture Capital Vignettes." Harvard Business School Case 801-408, March 2001. (Revised February 2005.)
- September 2011 (Revised August 2012)
- Background Note
The Venture Capital Problem Set
By: William Sahlman, Evan W. Richardson and James McQuade
This note consists of three valuation/analysis exercises often found in venture capital financing deals. View Details
Keywords: Venture Capital; Financing and Loans; Management Analysis, Tools, and Techniques; Negotiation Deal; Valuation
Sahlman, William, Evan W. Richardson, and James McQuade. "The Venture Capital Problem Set." Harvard Business School Background Note 812-039, September 2011. (Revised August 2012.)
- November 2022
- Course Overview Note
Launching Technology Ventures (LTV)
Bussgang, Jeffrey J. "Launching Technology Ventures (LTV)." Harvard Business School Course Overview Note 823-058, November 2022.